GE HealthCare Technologies Inc. (GEHC)
| Market Cap | 34.06B |
| Revenue (ttm) | 19.80B |
| Net Income (ttm) | 2.18B |
| Shares Out | 457.88M |
| EPS (ttm) | 4.76 |
| PE Ratio | 15.63 |
| Forward PE | 18.60 |
| Dividend | $0.14 (0.19%) |
| Ex-Dividend Date | Apr 25, 2025 |
| Volume | 6,625,448 |
| Open | 75.20 |
| Previous Close | 74.86 |
| Day's Range | 74.08 - 75.57 |
| 52-Week Range | 57.65 - 94.80 |
| Beta | 1.29 |
| Analysts | Strong Buy |
| Price Target | 88.80 (+19.39%) |
| Earnings Date | Jul 30, 2025 |
About GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided ther... [Read more]
Financial Performance
In 2024, GEHC's revenue was $19.67 billion, an increase of 0.61% compared to the previous year's $19.55 billion. Earnings were $1.99 billion, an increase of 43.90%.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for GEHC stock is "Strong Buy." The 12-month stock price forecast is $88.8, which is an increase of 19.39% from the latest price.
News
FDA Approves Expanded Indications for GE HealthCare's Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer's Patients
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--FDA approves expanded indications for GE HealthCare's Vizamyl PET imaging agent for beta amyloid detection, enabling more precise care for Alzheimer's.
GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare's commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on full display at this week's Society of Nuclear Medic...
GE Healthcare: Near-Term Margin Headwinds Priced In, Long-Term Growth Driven By New Products And M&As
GE Healthcare is well-positioned for growth, driven by a strong backlog, product innovation, and potential pent-up demand in China as stimulus funding is deployed. Margin headwinds from tariffs are ex...
GE HealthCare drives innovation in theranostics with latest technological advances
CHICAGO--(BUSINESS WIRE)--At this year's Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfo...
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
CHICAGO--(BUSINESS WIRE)--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions...
GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) proudly announces the combination of GE HealthCare's proprietary features and algorithms with MIM Encore, marking a significant milestone in its ...
GE HealthCare: The Demand Is Just Too Strong To Ignore
GE HealthCare's diverse business model, strong demand, and leadership in key segments position it well for long-term growth, especially with an aging population tailwind. Recent tariff volatility has ...
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
BOCA RATON, Fla. , June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp.
GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of CleaRecon DL, technology powered by a deep-learning algorithm, to improve the quality of cone-beam computed tomogra...
GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company's Optison™ (Perfl...
GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology
CHICAGO & SAN RAMON, Calif.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that coul...
GE HealthCare unveils ultra-premium, high-performance gradient 1.5T MRI system
HONOLULU--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA™ Sprint, an FDA 510(k) pending1 ultra-premium wide bore 1.5T high-performance gradient MRI system, at the International Soc...
ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the...
GE HealthCare's Strong Q1 Took Back Seat To Tariffs, Analyst Sees 2026 Tariff Impact Less Than 2025
On Wednesday, GE HealthCare GEHC reported first-quarter 2025 adjusted EPS of $1.01, which beat the consensus of 91 cents. It was up from 90 cents a year ago.
GE Healthcare sees tariffs costing $500 million in 2025, then much less next year
GE Healthcare sees bilateral China tariffs accounting for most of the expected tariff cost, or roughly 75%.
GE HealthCare Blames Tariffs For Lowering 2025 Profit Outlook, Initiates Stock Buyback
On Wednesday, GE HealthCare GEHC reported first-quarter 2025 adjusted EPS of $1.01, which beat the consensus of 91 cents. It was up from 90 cents a year ago.
GE HealthCare Technologies Inc. (GEHC) Q1 2025 Earnings Call Transcript
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Q1 2025 Earnings Conference Call April 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - Pres...
GE HealthCare beats on earnings, slashes full year outlook due to tariffs
GE HealthCare reported better-than-expected first-quarter results, beating analysts' estimates on top and bottom lines. The company slashed its annual forecast to account for the impact of President D...
GE HealthCare Results Top Estimates But Firm Cuts Profit Outlook Over Tariffs
GE HealthCare Technologies (GEHC) on Wednesday posted first-quarter results that came in better than analysts had expected, but the former General Electric division lowered its full-year profit outloo...
GE HealthCare cuts annual profit forecast on tariff impact
GE HealthCare Technologies trimmed its full-year profit forecast on Wednesday, as it expects a hit from U.S. President Donald Trump's tariffs.
GE HealthCare reports first quarter 2025 financial results
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the first quarter ended March 31, 2025. GE HealthCare President and CEO Peter Arduini said, “First quarter r...
GE HealthCare management to present at upcoming investor conferences
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. Bank of America Securities Healthc...
GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a global leader in breast health technology, will feature its latest advancements in diagnostic accuracy and patient-centered br...
GE HealthCare to announce first quarter 2025 results on April 30, 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its first quarter 2025 financial results before the market opens on Wednesday, April 30, 2025. The GE HealthCare management team wi...
Cincinnati Children's and GE HealthCare build collaborative research program to drive pediatric imaging innovation
CHICAGO--(BUSINESS WIRE)--Cincinnati Children's and GE HealthCare (Nasdaq: GEHC) will form a strategic research program focused on driving clinical and technical research to advance innovation for ped...